Profile
David John King is the founder of Lassen Therapeutics LLC, founded in 2019, serving as Chief Security Officer since 2019.
Dr. King is the founder of Lassen Therapeutics, Inc., founded in 2019, serving as Chief Scientific Officer since 2019.
Former jobs include Senior Director-Molecular Biology & Biochemistry at Medarex, Inc., Director-Molecular Biology & Biochemistry at Coulter Pharmaceuticals, Inc., Director-Molecular Biology & Biochemistry at Corixa Corp., Chief Scientific Officer at aTyr Pharma, Inc. in 2018, Chief Scientific Officer at AnaptysBio, Inc. from 2011 to 2016, Scientist-Head Protein Biochem at Celltech Ltd., and Senior Vice President-Research at Tunitas Therapeutics, Inc. in 2016.
Education includes undergraduate studies at the University of Warwick and a doctorate from the University of Surrey.
David King active positions
| Companies | Position | Start |
|---|---|---|
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Founder | 2018-12-31 |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Founder | 2018-12-31 |
Former positions of David King
| Companies | Position | End |
|---|---|---|
| ATYR PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2018-12-30 |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of allergy | Chief Tech/Sci/R&D Officer | 2016-08-31 |
| ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | 2016-01-31 |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural science and engineering | Corporate Officer/Principal | - |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Corporate Officer/Principal | - |
Training of David King
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of Warwick
University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural science and engineering | Commercial Services |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of allergy | Health Technology |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Commercial Services |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Health Technology |
- Stock Market
- Insiders
- David King
















